MIRA Pharmaceuticals (MIRA) Expected to Announce Quarterly Earnings on Monday

MIRA Pharmaceuticals (NASDAQ:MIRA) is projected to issue its quarterly earnings data before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter.

MIRA Pharmaceuticals (NASDAQ:MIRA) last posted its earnings results on Friday, March 28th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.14. On average, analysts expect MIRA Pharmaceuticals to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

MIRA Pharmaceuticals Stock Performance

Shares of MIRA opened at $0.83 on Friday. The business’s 50-day moving average is $1.10 and its two-hundred day moving average is $1.21. The company has a market capitalization of $14.03 million, a P/E ratio of -1.49 and a beta of 2.05. MIRA Pharmaceuticals has a fifty-two week low of $0.51 and a fifty-two week high of $5.01.

About MIRA Pharmaceuticals

MIRA Pharmaceuticals, Inc operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.